Not applicableApproved For MarketingNCT01632826
What this trial is testing
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Who this might be right for
Multiple Myeloma
Celgene